Analysis of phenotype, genotype and serotype distribution in erythromycin-resistant group B streptococci isolated from vaginal flora in Southern Ireland

被引:5
作者
Kiely, R. A. [1 ,2 ]
Lucey, B. [1 ,2 ]
Cotter, L. [1 ]
机构
[1] Cork Inst Technol, Dept Biol Sci, Cork, Ireland
[2] Cork Univ Hosp, Dept Med Microbiol, Cork, Ireland
关键词
Antibiotic resistance; clinical microbiology; epidemiology; streptococcal infections; MACROLIDE RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; CLINICAL STRAINS; AGALACTIAE; MECHANISMS; COLONIZATION; DETERMINANTS; PNEUMONIAE;
D O I
10.1017/S0950268809990392
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The screening of 2000 women of childbearing age in Cork between 2004 and 2006 produced 37 erythromycin-resistant group B streptococcus (GBS) isolates. PCR analysis was performed to determine the basis for erythromycin resistance. The ermTR gene was most frequently expressed (n = 19), followed by the ermB gene (n = 8). Four isolates harboured the mefA gene. Six isolates yielded no PCR products. Some phenotype-genotype correlation was observed. All isolates expressing the mefA gene displayed the M phenotype whilst all those expressing ermB displayed the constitutive macrolide resistance (cMLS(B)) phenotype. Of 19 isolates that expressed the ermTR gene, 16 displayed the inducible macrolide resistance (iMLS(B)) phenotype. Serotype analysis revealed that serotypes III and V predominated in these isolates. The identification of two erythromycin-resistant serotype VIII isolates among this collection represents the first reported finding of erythromycin resistance in this serotype. A single isolate was non-typable using two latex agglutination serotyping kits.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 34 条
  • [1] Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital
    Acikgoz, ZC
    Almayanlar, E
    Gamberzade, S
    Gocer, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1410 - 1412
  • [2] AYNUR A, 2005, TURKISH J PAEDIAT, V47, P28
  • [3] BARCAITE E, 2007, PREVALENCE INCIDENCE
  • [4] Frequency of antimicrobial resistance among invasive and colonizing Group B Streptococcal isolates
    Borchardt, SM
    DeBusscher, JH
    Tallman, PA
    Manning, SD
    Marrs, CF
    Kurzynski, TA
    Foxman, B
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [5] Epidemiology of Streptococcus agalactiae colonization in Germany
    Brimil, N
    Barthell, E
    Heindrichs, U
    Kuhn, M
    Lütticken, R
    Spellerberg, B
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 296 (01) : 39 - 44
  • [6] Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
  • [7] Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae
    Culebras, E
    Rodriguez-Avial, I
    Betriu, C
    Redondo, M
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1574 - 1576
  • [8] Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil
    D'Oliveira, REC
    Barros, RR
    Mendonça, CRV
    Teixeira, LM
    Castro, ACD
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (11) : 1029 - 1030
  • [9] Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women:: Relationship to colonization status and infection in the neonate
    Davies, HD
    Adair, C
    McGeer, A
    Ma, D
    Robertson, S
    Mucenski, M
    Kowalsky, L
    Tyrell, G
    Baker, CJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03) : 285 - 291
  • [10] Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae:: French multicenter study
    De Mouy, D
    Cavallo, JD
    Leclercq, R
    Fabre, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2400 - 2402